Recombinant Human Coagulation Factor IX Protein, CF

R&D Systems | Catalog # 9260-SE

R&D Systems
100% Guarantee

Key Product Details

  • R&D Systems HEK293-derived Recombinant Human Coagulation Factor IX Protein (9260-SE)
  • Quality control testing to verify active proteins with lot specific assays by in-house scientists
  • All R&D Systems proteins are covered with a 100% guarantee

Source

HEK293

Accession Number

P00740

Applications

Enzyme Activity
View all Coagulation Factor IX Proteins and Enzymes »

Product Specifications

Source

Human embryonic kidney cell, HEK293-derived human Coagulation Factor IX protein
Thr29-Thr461, with a C-terminal Fc tag

Purity

>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.

Endotoxin Level

<1.0 EU per 1 μg of the protein by the LAL method.

N-terminal Sequence Analysis

Thr29 (pro-mature) and Tyr47 (mature)

Predicted Molecular Mass

75 kDa

SDS-PAGE

86-104 kDa, reducing conditions

Activity

Measured by its ability to cleave the fluorogenic peptide substrate, Mca-RPKPVE-Nval-WRK(Dnp)-NH2 (Catalog # ES002).
The specific activity is >30 pmol/min/μg, as measured under the described conditions.

Scientific Data Images for Recombinant Human Coagulation Factor IX Protein, CF

Recombinant Human Coagulation Factor IX Protein Enzyme Activity

Recombinant Human Coagulation Factor IX Protein Enzyme Activity

Recombinant Human Coagulation Factor IX (Catalog # 9260-SE) is measured by its ability to cleave the fluorogenic peptide substrate, MCA-RPKPVE-Nval-WRK(Dnp)-NH2 (Catalog # ES002).

Formulation, Preparation, and Storage

9260-SE
Formulation Supplied as a 0.2 μm filtered solution in Tris and NaCl.
Shipping The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 6 months from date of receipt, -20 to -70 °C as supplied.
  • 3 months, -20 to -70 °C under sterile conditions after opening.

Background: Coagulation Factor IX

Coagulation Factor IX, also known as Christmas Factor, is a secreted by the liver and plays a key role in the activation of the intrinsic clotting cascade (1). Factor IX consists of a Gla domain, two tandem EGF-like domains, an activation peptide, and an S1 serine protease domain (2). Mature human Factor IX shares approximately 81% amino acid sequence identity with mouse and rat Factor IX. Alternative splicing generates an additional isoform that lacks the first EGF-like domain. The Gla domain is modified by Vitamin K-dependent gamma-carboxylation and mediates the association of Factor IX with phospholipid bilayers (3, 4). The activation peptide is removed by Factor XIa mediated cleavage, resulting in heavy and light chains that remain disulfide-linked (5). Factor IX can also be activated by proteolytic factors in multiple snake venoms (6, 7). Active Factor IX associates with Factor VIIIa on the platelet surface where it cleaves and activates Factor X, leading to Fibrin deposition and clot formation (8-10). The human Factor IX gene is highly polymorphic, and Hemophilia B can be caused by X-linked deficiency of Factor IX activity (11-14).

References

  1. Smith, S.A. et al. (2015) Crit. Rev. Biochem. Mol. Biol. 50:326.
  2. Kurachi, K. and E.W. Davie (1982) Proc. Natl. Acad. Sci. USA 79:6461.
  3. Rawala-Sheikh, R. et al. (1992) Blood 79:398.
  4. Freedman, S.J. et al. (1996) J. Biol. Chem. 271:16227.
  5. Di Scipio, R.G. et al. (1978) J. Clin. Invest. 61:1528.
  6. Takeya, H. et al. (1992) J. Biol. Chem. 267:14109.
  7. Sajevic, T. et al. (2011) Toxicon 57:627.
  8. Ahmad, S.S. et al. (2003) J. Thromb. Haemost. 1:2348.
  9. Mathur, A. et al. (1997) J. Biol. Chem. 272:23418.
  10. van Dieijen, G. et al. (1985) Thromb. Haemost. 53:396.
  11. Aguilar-Martinez, P. et al. (1994) Hum. Genet. 94:287.
  12. Davis, L.M. et al. (1987) Blood 69:140.
  13. Bertina, R.M. et al. (1990) J. Biol. Chem. 265:10876.
  14. Girolami, A. et al. (2015) Semin. Thromb. Hemost. 41:359.

Alternate Names

Christmas Factor, F9, FIX, HEMB, P19, Plasma Thromboplastic Component, PTC, THPH8

Entrez Gene IDs

2158 (Human); 14071 (Mouse); 24946 (Rat)

Gene Symbol

F9

UniProt

P00740

Additional Coagulation Factor IX Products

Product Documents for Recombinant Human Coagulation Factor IX Protein, CF

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot or batch number in the search box below.

Note: Certificate of Analysis not available for kit components.

Download SDS

Product Specific Notices for Recombinant Human Coagulation Factor IX Protein, CF

For research use only

Citations for Recombinant Human Coagulation Factor IX Protein, CF

Customer Reviews for Recombinant Human Coagulation Factor IX Protein, CF

There are currently no reviews for this product. Be the first to review Recombinant Human Coagulation Factor IX Protein, CF and earn rewards!

Have you used Recombinant Human Coagulation Factor IX Protein, CF?

Submit a review and receive an Amazon gift card!

$25/€18/£15/$25CAN/¥2500 Yen for a review with an image

$10/€7/£6/$10CAN/¥1110 Yen for a review without an image

Submit a review
Amazon Gift Card

Protocols

View specific protocols for Recombinant Human Coagulation Factor IX Protein, CF (9260-SE):

Materials
  • Assay Buffer: 100 mM Tris, 10 mM CaCl2, 150 mM NaCl, 0.05% (w/v) Brij-35, pH 8.0
  • Recombinant Human Coagulation Factor IX (rhFactor IX) (Catalog # 9260-SE)
  • Bacterial Thermolysin (Thermolysin) (Catalog # 3097-ZN)
  • Substrate: Fluorogenic Peptide Substrate II, MCA-Arg-Pro-Lys-Pro-Val-Glu-NVAL-Trp-Arg-Lys(DNP)NH2 (Catalog # ES002)
  • 1,10-Phenanthroline (Sigma, Catalog # 320056)
  • F16 Black Maxisorp Plate (Nunc, Catalog # 475515)
  • Fluorescent Plate Reader (Model: SpectraMax Gemini EM by Molecular Devices) or equivalent
  1. Activate rhFactor IX at 100 µg/mL wih 10 µg/mL Thermolysin in Assay Buffer.
  2. Incubate at 37 °C for 90 minutes.
  3. Stop the reaction by adding 1,10-Phenanthroline to the reaction tube at a final concentration of 10 mM.
  4. Dilute activated rhFactor IX to 4 ng/µL in Assay Buffer.
  5. Dilute Substrate to 20 µM in Assay Buffer.
  6. Load 50 µL of the 4 ng/µL rhFactor IX into a black well plate, and start the reaction by adding 50 µL of 20 µM Substrate.  Include a Substrate Blank containing 50 µL Assay Buffer and 50 µL 20 µM Substrate.
  7. Read at excitation and emission wavelengths of 320 nm and 405 nm (top read), respectively, in kinetic mode for 5 minutes.
  8. Calculate specific activity:

     Specific Activity (pmol/min/µg) =

 Adjusted Vmax* (RFU/min) x Conversion Factor** (pmol/RFU)
amount of enzyme (µg)

      *Adjusted for Substrate Blank
      **Derived using calibration standard MCA-Pro-Leu-OH (Bachem, Catalog # M-1975)

Per Well:

  • rhFactor IX: 0.2 µg
  • Substrate: 10 µM

FAQs

No product specific FAQs exist for this product.

View all FAQs for Proteins and Enzymes